“ventirx-pharmaceuticals” Archives

in
Entry Author Date Location
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
VentiRx Pharmaceuticals Secures $19,352,414 New Financing Round 09/23/14 Seattle
Just 7 Tickets Left for Our What’s Hot in Cancer Event April 22 04/21/14 Seattle
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Celgene Nabs Option to Buy Acetylon for More Than $1.7B 07/29/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
Presage Snags $13M from Celgene to Pick Winning Cancer Drug Combos 03/05/13 Seattle
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Genoa Pharma Aims To Satisfy Big Pharma’s Hunger for IPF Drugs 03/30/12 San Diego
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Ion Torrent Racing to Change Healthcare, VentiRx to Close SD Office, RF Surgical Raises $12M, and More San Diego Life Sciences News 09/15/11 San Diego
Dendreon Slashes 500 Jobs, Gates Foundation Adds Novartis Exec, Theraclone Tacks on $10M, & More Seattle-Area Life Sciences News 09/15/11 Seattle
VentiRx Concentrates Its Bet on Cancer, and Seattle 09/13/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News 06/09/11 San Diego
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO 11/12/10 Seattle
Seattle Genetics Nails 2nd Trial, Bristol Clinches Zymo Buyout, Halosource Goes Public, & More Seattle-Area Life Sciences News 10/14/10 Seattle
San Diego’s Mini-Cluster of Virtual Biotechs Without Labs on High Bluff Drive 10/13/10 San Diego
VentiRx, With Venti-Sized Ambition to Treat (and Maybe Prevent) Allergies, Passes First Big Test 10/07/10 Seattle
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News 10/07/10 Seattle
VentiRx Cancer Drug Passes Early Trial 10/04/10 San Diego
Lorcaserin Weight-Loss Trials Weigh Heavily on Arena, Ramius Raises Offer to Buy Cypress Bio, Santarus Adds to Its Drug Portfolio, & More San Diego Life Sciences News 09/16/10 San Diego
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond 09/15/10 National
Page 1 of 2 next page »